Last update: June 4, 2016


Very Low Risk for breastfeeding

Safe. Compatible.
Minimal risk for breastfeeding and infant.

At latest update no published data on excretion into breast milk were found.

The small dose and low plasma absorption of most topical ophthalmic preparations make it unlikely the passage of significant amount of such a product to breast milk, so the use as ophthalmic eye drops poses a very low risk while breastfeeding.
In addition, its short half-life and high plasma protein binding capacity make it even more unlikely any passage to the breast milk.

After application, press onto the tear sac or close the eyelids tightly for a couple of minutes (nasolacrimal occlusion) to minimize systemic absorption.


We do not have alternatives for Bimatoprost since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Bimatoprost in other languages or writings:


Bimatoprost belongs to this group or family:


Main tradenames from several countries containing Bimatoprost in its composition:


Variable Value Unit
Molecular weight 416 daltons
Protein Binding 88 %
VD 0,67 l/Kg
Tmax 0,2 hours
T1/2 0,75 hours


  1. EMA. Bimatoprost. Ficha técnica. 2016 Full text (in our servers)
  2. EMA. Bimatoprost. Drug Summary. 2016 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM